Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

NDAQ:LEXX - Post Discussion

Lexaria Bioscience Corp > LEXX.....Go read the President 's msg to Sh Holders
View:
Post by Iseneschal on Jan 24, 2024 12:27pm

LEXX.....Go read the President 's msg to Sh Holders

Normally ...I'm pretty hard on Directors.....but this guy just told it like it was !

Seriously...Mr. Bunka did an honorable job with that....go read the whole letter.

 

Lexaria Releases Annual Letter from the CEO

 

2024-01-24 05:48 ET - News Release

 

KELOWNA, BC / ACCESSWIRE / January 24, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX),(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide this annual letter from CEO Chris Bunka as a strategic update to all stakeholders.

Comment by lscfa on Jan 24, 2024 1:23pm
Excerpt:   The pharmaceutical industry values drug delivery technology more wholesomely than does the CPG industry. This is apparent in the 2020/21 transaction whereby Novo Nordisk paid US$1.8 billion to acquire Emisphere Technologies Inc. Emisphere® developed a drug delivery technology now known as SNAC, “which facilitates the enhanced oral absorption of ...more  
Comment by Yowza123 on Jan 25, 2024 1:31pm
Bunka is the CEO, John Docherty is the President but yeah, getting exciting here!!
Comment by Iseneschal on Feb 14, 2024 1:08pm
Just to let the SH Audience know..... LEXX was $1.57 on Jan 24th...... Today it is trading at $2.66...that my friends is over $1.00 profit Please give thanks  and donate a small portion to your favourite Charity Cheers !